These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7060855)

  • 1. [Pharmacokinetics of dihydroergotamine in patients with chronic liver disease (author's transl)].
    Labayle D; Chalas J; Lavène D; Humbert M; Azria M; Lindenbaum A; Chaput JC
    Gastroenterol Clin Biol; 1982 Feb; 6(2):129-34. PubMed ID: 7060855
    [No Abstract]   [Full Text] [Related]  

  • 2. The hepatointestinal extraction of radiolabelled zinc and altered plasma concentration time curve to oral zinc in chronic liver disease: a mechanism for hyperzincuria in alcoholic cirrhosis.
    Keeling PW; Ruse W; Thompson RP
    Prog Clin Biol Res; 1983; 129():125-38. PubMed ID: 6657699
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thyroid gland and thyroid status in patients with chronic liver diseases].
    Podymova SD; Ulanova IN; Bolśhakova TD; Khomiakova VN
    Klin Med (Mosk); 1997; 75(3):32-5. PubMed ID: 9229611
    [No Abstract]   [Full Text] [Related]  

  • 4. Tissue zinc status in patients with chronic liver disease.
    Keeling PW; Thompson RP
    Prog Clin Biol Res; 1983; 129():235-54. PubMed ID: 6657706
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sulfobromophthalein kinetics in normal subjects and patients with alcoholic cirrhosis (author's transl)].
    Biagi P; Bocchini S; Vernarecci G
    Quad Sclavo Diagn; 1979 Sep; 15(3):1007-16. PubMed ID: 554996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The determination of the intestinal clearance of alpha-1-antitrypsin in patients with alcoholic cirrhosis (author's transl)].
    Beaugrand M; Trinchet JC; Vaysse J; Hecht Y; Garnier M; Ferrier JP
    Gastroenterol Clin Biol; 1982 Jan; 6(1):62-7. PubMed ID: 6978272
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chronic alcoholic liver disease. Ionized blood calcium measurements in 24 patients (author's transl)].
    Louboutin JY; Feuillu A; Bansard JY; Brissot P; Pawlotsky Y; Bourel M
    Nouv Presse Med; 1980 May; 9(24):1689-90. PubMed ID: 7465398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The translation of the program-information about the protein-synthesis in the liver in chronic liver diseases (author's transl)].
    Damjanow B; Nikolowa W
    Dtsch Z Verdau Stoffwechselkr; 1980; 40(3-4):127-31. PubMed ID: 7449709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autonomic neuropathy in chronic liver diseases].
    Kempler P; Szalay F; Váradi A; Hermányi Z; Marton A; Fazekas K
    Orv Hetil; 1993 Apr; 134(16):853-7. PubMed ID: 8469564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative study of alminoprofene elimination in healthy subjects and in patients with renal or hepatic insufficiency (author's transl)].
    Premel-Cabic A; Chaleil D; Bonniot R; Riberi P; Streichenberger G; Allain P
    Therapie; 1981; 36(1):41-6. PubMed ID: 7233371
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Abnormalities of ten plasma proteins in alcoholic liver disease (author's transl)].
    Nalpas B; Boigné JM; Zafrani ES; Zimmermann R; Berthelot P
    Gastroenterol Clin Biol; 1980 Oct; 4(10):646-54. PubMed ID: 7439609
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic and blood lead levels in patients with chronic liver disease.
    Castilla L; Castro M; Grilo A; Guerrero P; Lopez-Artiguez M; Soria ML; Martinez-Parra D
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):243-9. PubMed ID: 7743306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential depletion of carotenoids and tocopherol in liver disease.
    Leo MA; Rosman AS; Lieber CS
    Hepatology; 1993 Jun; 17(6):977-86. PubMed ID: 8514270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative bioavailability of two oral forms of dihydroergotamine (author's transl)].
    Luccioni F; Kiechel JR
    Therapie; 1979; 34(5):625-34. PubMed ID: 583555
    [No Abstract]   [Full Text] [Related]  

  • 16. Alcohol-related cirrhosis with pancreatitis. The role of oxidative stress in the progression of the disease.
    Szuster-Ciesielska A; Daniluk J; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2001; 49(2):139-46. PubMed ID: 11348018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ultrasound measurement of gallbladder response to cholecystokinin in patients with chronic liver disease (author's transl)].
    Schwerk WB; Schack K; Bode JC
    Z Gastroenterol; 1981 Nov; 19(11):717-24. PubMed ID: 7314756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibody activity in some chronic liver diseases (author's transl)].
    Macák J
    Cas Lek Cesk; 1976 Dec; 115(48):1483-6. PubMed ID: 1000564
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics of dihydroergotamine in healthy volunteers and in neurological patients after a single intravenous injection.
    Kanto J; Allonen H; Koski K; Koulu M; Lammintausta R; Mäntylä R; Kleimola T; Siirtola T
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):127-30. PubMed ID: 7228454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.